Haleos Labs Limited Share Price

Q: What is the share price of Haleos Labs Limited today?

Haleos Labs Limited share price as on 30 Nov 2025 is ₹1370.0

Pharmaceuticals

NSE: HALEOSLABS Small Cap ISIN: INE320X01016

As on 01 December 2025 at 04:40 IST

₹1,370

+ 17.80

(1.32%)

Sell Buy

Over 1 Month

20.78%

Over 6 Months

-0.85%

Over 1 Year

16.54%

Over 3 Years

104.17%

Haleos Labs Limited Summary

Close ₹1,352.20

Open ₹1,370.10

High ₹1,389.90

Low ₹1,322.30

Volume 3,367

Net Turnover (in Cr) ₹0.45

52Wk High ₹1,680

52Wk Low ₹959.80

52Wk High / Low

959.80

1,680

Haleos Labs Limited Fundamentals

Key Financial Data

Market Cap (in Cr) ₹408.81

EPS (TTM) 62.97

Book Value (BV) 684.27

Div. Yield 0.11 %

P/E (TTM) 21.47

Price/Book Value 1.98

Delivery % 68.31 %

Face Value 10

Key Ratios

PE Ratio 15.28

PB Ratio 1.66

EV to Sales 1.22

PEG Ratio 0.24

ROA 7.55

ROE 11.45

Debt-Equity 0.46

Net Profit Margin 5.80

Operating Profit Margin 13.10

Haleos Labs Limited Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	349.58	309.79	318.63	351.81	267.37
Total Expenses	323.39	299.94	304.39	331.77	247.81
Profit Before Tax	26.19	9.85	16.59	32.73	19.57
Profit After Tax	18.73	6.33	11.38	25.30	13.56
Operating Profit After Depreciation	34.90	20	21.04	26.21	24.10

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	231.85	223.34	228.36	142.03	129.78
Total Non Current Assets	239.42	235.25	235.77	200.73	176.01
Total Current Assets	150.57	156.08	159.12	156.02	126.29
Total Assets	389.99	391.33	394.89	356.75	302.30
Total Shareholder's Fund	196.56	176.81	168.61	152.23	129.22

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	34.06	24.31	14.70	-11.24	35.17
Net Cash Used In Investing Activities	-15	-18.45	-31.29	-7.14	-26.23
Net Cash Used In Financing Activities	-19.12	-6.56	16.89	10.83	-2.55

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	337.32	303.84	318.12	347.16	261.59
Total Expenses	307.28	284.73	302.10	326.88	242.23
Profit Before Tax	30.04	19.11	18.37	32.98	19.35
Profit After Tax	21.37	13.07	13.22	25.38	13.17
Operating Profit After Depreciation	37.92	28.01	21.12	24.91	23.85

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	150.23	138.23	139.61	98.72	100.83
Total Non Current Assets	180.52	172.88	169.80	149.68	136.32
Total Current Assets	177.79	175.35	167.59	162.32	135.43
Total Assets	358.31	348.24	337.39	312	271.74
Total Shareholder's Fund	197.18	176.23	164.03	151.21	126.34

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	28.03	14.75	4.58	-14.66	21.62
Net Cash Used In Investing Activities	-13.77	-13.75	-27.96	-7.49	-5.94
Net Cash Used In Financing Activities	-14.20	-0.82	22.59	14.63	-7.87

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	81.37	82.50	89.11	84.60	78.46
Total Expenses	67.79	70.79	81.69	71.84	69.90
Profit Before Tax	8.49	7.02	3.93	6.92	4.70
Profit After Tax	6.43	4.38	3.48	4.85	3.30
Operating Profit after Depreciation	14	12.71	9.76	12.82	10.60

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	77.84	79.04	85.43	82.88	78.50
Total Expenses	67.05	68.21	79.83	69.81	66.70
Profit Before Tax	7.04	7.48	3.34	8.61	8.57
Profit After Tax	4.98	5.16	2.68	6.23	6.01
Operating Profit after Depreciation	11.23	11.84	7.80	13.13	13.06

Haleos Labs Limited Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,319.70

S2 1,287.20

S3 1,252.10

Pivot 1,354.80

R1 1,387.30

R2 1,422.40

R3 1,454.90

Moving Average

20 SMA 1,273.18

50 SMA 1,203.62

100 SMA 1,180.35

200 SMA 1,205.03

Haleos Labs Limited Corporate Actions

Haleos Labs Limited

₹1.5/Share

Announcement Date 24 Sep 2025

Record Date 24 Sep 2025

Div Yield 15%

AGM Date: 30 Sep 2021

AGM 30/09/2021 SMS Lifesciences India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Outcome of 15th Annual General Meeting held on September 30, 2021. (As Per BSE announcement Dated on 01.10.2021)

AGM Date: 30 Sep 2022

Enclosed is the Outcome of the Board Meeting. Events calendar related to the 16th Annual General Meeting (As Per BSE Announcement Dated on 30/08/2022) Enclosed is the notice of 16th Annual General Meeting of the Company. (As Per BSE Announcement Dated 08.09.2022) Outcome of 16th Annual General Meeting held on September 30, 2022 along with Scrutinizer Report. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 29 Sep 2023

Enclosed is the Outcome of the Board Meeting (Q1F24 Results / AGM date / Board Report approval). Register of members and Share Transfer Books of the Company will remain closed from Saturday, September 23, 2023 to Friday, September 29, 2023 (both days inclusive) & record date for Dividend and AGM will be Friday, September 22, 2023. (As per BSE Announcement Dated on 22/08/2023) Enclosed is the notice of the 17th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 07/09/2023) Outcome of the 17th Annual General Meeting held on September 29, 2023, along with Scrutinizers Report. (As Per BSE Announcement dated on 29.09.2023)

AGM Date: 30 Sep 2024

Outcome of Board meeting Register of members and share transfer books of the Company will remain closed from Tuesday, September 24, 2024 to Monday, September 30, 2024 and the Record date for dividend and AGM will be Monday, September 23, 2024. (As Per BSE Announcement dated on 24.08.2024) Outcome of 18th Annual General Meeting of the Company. (As per BSE Announcement dated on 30/09/2024)

AGM Date: 30 Sep 2025

Events Calendar related to the 19th Annual General Meeting. Summary of proceedings of 19th Annual General Meeting. (As Per BSE Announcement Dated on: 30.09.2025) Voting result of 19th Annual General Meeting. (As Per BSE Announcement Dated on:01.10.2025)

Haleos Labs Limited Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,809.50	₹4,34,159.66
Divis Laboratories Ltd	₹6,489.95	₹1,72,287.78
Torrent Pharmaceuticals Ltd	₹3,735.90	₹1,26,434.15
Cipla Ltd	₹1,524.55	₹1,23,148.76
Dr Reddys Laboratories Ltd	₹1,250.50	₹1,04,369.38

Haleos Labs Limited Top Mutal Funds Invested

No data available

Haleos Labs Limited News

SMS LifeSciences India announces board meeting date

On 10 November 2025

05 Nov 2025, 04:14 pm

SMS LifeSciences India AGM scheduled

On 30 September 2025

29 Aug 2025, 03:54 pm

SMS LifeSciences India to table results

On 11 August 2025

08 Aug 2025, 12:44 pm

SMS Lifesciences India Ltd leads gainers in 'B' group

Magellanic Cloud Ltd, Fischer Medical Ventures Ltd, Global Surfaces Ltd and 20 Microns Ltd are among the other gainers in the BSE's 'B' group today, 16 July 2025.

16 Jul 2025, 12:15 pm

Board of SMS LifeSciences India recommends final dividend

Of Rs 1.5 per share

30 May 2025, 11:19 am

Haleos Labs Limited Stock Analysis

Annual revenue for Haleos Labs Limited increased by 11.02% to ₹337.32 crore in FY 2025 from ₹303.84 crore in FY 2024.
Annual Net Profit for Haleos Labs Limited increased by 63.57% to ₹21.37 crore in FY 2025 from ₹13.07 crore in FY 2024.
Promoter Shareholding in Haleos Labs Limited remains unchanged by 0.00% in the most recent quarter, from 71.41% in June 2025 to 71.41% in September 2025.
Haleos Labs Limited delivered a 1-year return of 16.54% compared to the Nifty 50, which provided a return of 7.99% as of the last trading session.
Haleos Labs Limited share price moved up by 1.32% from its previous close of INR ₹1,352.20. The latest Haleos Labs Limited share price is INR ₹1,370.
Haleos Labs Limited share price today has been at a low of 1,367.30 and a high of 1,373.50. Over the past 52 weeks, the Haleos Labs Limited share price has seen a low of 959.80 and a high of 1,680.